Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy
Shuyan He,
No information about this author
Lu Zheng,
No information about this author
Chunjian Qi
No information about this author
et al.
Molecular Cancer,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: Jan. 8, 2025
Language: Английский
Lipid Nanoparticles and PEG: Time Frame of Immune Checkpoint Blockade Can Be Controlled by Adjusting the Rate of Cellular Uptake of Nanoparticles
Andrew S. Choi,
No information about this author
Taylor J. Moon,
No information about this author
Anubhuti Bhalotia
No information about this author
et al.
Molecular Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 4, 2025
The
engineerability
of
lipid
nanoparticles
(LNPs)
and
their
ability
to
deliver
nucleic
acids
make
LNPs
attractive
tools
for
cancer
immunotherapy.
LNP-based
gene
delivery
can
be
employed
various
approaches
in
immunotherapy,
including
encoding
tumor-associated
antigens
silencing
negative
immune
checkpoint
proteins.
For
example,
carrying
small
interfering
RNAs
offer
several
advantages,
sustained
durable
inhibition
an
protein.
Due
tunable
design,
modifying
the
composition
regulate
rate
uptake
by
cells
silencing.
Controlling
kinetics
LNP
provides
additional
flexibility
strategies
generate
appropriate
immunomodulation
tumor
microenvironment.
Here,
we
evaluated
effects
polyethylene
glycol
(PEG)
content
ranging
from
0.5
6
mol
%
on
cellular
PD-L1
after
intratumoral
administration.
We
blockade
vitro
cell
studies
vivo
using
YUMM1.7
melanoma
model.
Cell
showed
that
was
inversely
correlated
increasing
PEG
a
linear
relationship.
In
studies,
0.5%
initiated
immediate
effect
with
significant
decrease
expression
observed
within
24
h.
comparison,
6%
delayed,
subsets
being
72
h
Notably,
performance
at
comparable
Overall,
this
study
suggests
modifications
administration
promising
strategy
effective
antitumor
response.
Language: Английский
Enhanced delivery of lipid nanoparticle-based immunotherapy by modulating the tumor tissue stiffness using ultrasound-activated nanobubbles
Published: April 19, 2025
Abstract
Tumors
often
exhibit
an
extracellular
matrix
with
elevated
stiffness
due
to
excessive
accumulation
and
crosslinking
of
proteins,
particularly
collagen.
This
acts
as
a
physical
barrier,
impeding
the
infiltration
immune
cells
effective
delivery
various
immunotherapeutic
agents,
such
lipid
nanoparticle-based
RNA
therapeutics.
Here,
we
investigate
ability
ultrasound-activated
nanobubbles
(US-NBs)
increase
permeability
immunogenicity
tumors.
Our
results
show
that
US-NBs
physically
remodel
tumor
tissue
by
decreasing
its
60%
five
days
after
single
treatment.
US-NB-treated
tumors
display
randomly
oriented
collagen
5.47-fold
lower
deposition
compared
untreated
leads
widespread
distribution
nanoparticles
(LNPs)
in
tumor.
When
LNPs
are
assisted
US-NB,
they
have
higher
gene-transfection
across
pan-immune
relative
alone.
Notably,
US-NB
enables
genetically
modify
T
directly
vivo.
By
effectively
engaging
both
arms
system,
US-NB-assisted
enhance
cytotoxic
4-fold
when
These
indicate
gentle
mechanical
stimulation
using
offers
promising
strategy
augment
efficacy
existing
immunotherapies.
Graphical
Language: Английский